| |
IN THIS ISSUE |
| |
Dawn AC version 7.4 available soon
2007 15th User Group
USA User Group
Study suggests lower risk of prostate cancer in warfarin
users
|
 |
 |
Welcome to the June
edition of the DAWN AC Anticoagulation Software E-Newsletter for
2007.
|
Dawn AC Web Browser
version 7.4 available Soon! |
|
We will shortly
be releasing a Dawn AC version 7.4 upgrade within the next few
weeks. There
are several improvements made to this version since our last
release, a few of which are as follows:
- New
functionality to enable Dawn AC to send outbound messages which
can then be processed by an external application.
- New message
events are available, which allow the user to set up an
automatic message to be sent out when a patient treatment plan
is created or updated.
-
Health Care
professionals can be flagged as being Not In Use.
For further details on version 7.4
please contact us at
sales@4s-dawn.com.
|
Dawn AC
Anticoagulation Software 15th User Group 2007 |
|
This year's user group is shaping up to be another excellent
meeting! Please see our provisional agenda below.
It is essential that we receive your booking
forms as soon as possible to save disappointment.
Following the success of last years User Group, we have decided
to hold the event again in the popular Rheghed Centre. This is
because The Rheghed is actually much more accessible for
everybody to attend, as it is only two minutes off the M6
Motorway, J40.
The provisional
agenda so far is as follows:
"Anticoagulant
Safety Notice and Dawn AC"
Prof David
Cousins, UK National Patient Safety Agency & Syd Stewart, 4S
Dawn Software
"GAS and Safety Risks"
Sr Anne Marie Etherington, Lead Nurse Practitioner, Glasgow
Anticoagulation Service
"An Integrated Multicenter Solution with DAWN AC v7"
Lisa Vaughn,
RN CACP,
Nurse Clinician,
Wenatchee Valley Medical Center, USA
"How Dawn AC Operates in Belgium University Hospital"
Dr Cedric
Hermans, Consultant Haematologist, Cliniques Universitaires
Saint Luc, Brussels
"NEQAS – INR Dosing Survey Results"
Dr Rhona MacLean, Consultant Haematologist, Royal Hallamshire
Hospital, Sheffield
"Traveller’s Thrombosis"
Dr Patrick
Kesteven, Freeman Hospital, Newcastle upon Tyne
"First Episode DVT: Audit of Short and Long-term
outcome following Warfarin Treatment"
Dr David
Wright, Consultant Haematologist, Mid Yorkshire NHS Trust
"Automation: Embracing New Technologies to Improve the
Safety and Efficiency"
Steve
Davidson, Senior Clinical Nurse Specialist - Haemostasis &
Thrombosis Service,
Queens
Medical Centre, Nottingham
"Examination & Assessment of a Suspected DVT"
Sarah Munro,
Anticoagulation Sister, Treatment Centre, Luton and Dunstable
Hospital
"Service Specification for the Nurse Led Management of
Suspected DVT"
Alison
Meynell, Lead Nurse/ Anticoagulation Sister, Treatment Centre,
Luton and Dunstable Hospital
The User Group, as many of you know, offers the
chance for Health Care Professionals to share ideas and learn
alternative methods of best practice within Anticoagulation
therapy. As well as the day being informative and beneficial,
we try to make the event enjoyable by providing an evening
meal and entertainment within the package price.
We are keen to hear from those of you who would
like to give a short talk at the User Group Meeting, we are
offering a ‘speaker’s package’ where there will be a £100
reduction in the meeting fee and we also help with your
presentation preparation. Please remember that the meeting is
informal and so please don't hold back if you would like to
speak. In response to user requests, we invite you to share
how you use Dawn AC in different settings eg laboratory based,
community based with POC, pharmacist managed. In addition, we
would be interested in your experiences with Version 7.
The North American User Group is
going to be held on the 12th October in Denver, the day before
the South West Symposium on Thrombosis and Hemostasis, also
being held in Denver, making this, potentially, a very
informative and worthwhile trip.
Current speakers include:
- Dan Witt, Head of
Anticoagulation at Kaiser Permanente Colorado
- Priscilla DiCarlo, Manager of
Anticoagulation at Group Health Cooperative, Seattle
- Brian Schilling, Clinical
Pharmacist at Alaska Native Medical Center
- Amy Kramer, Pharmacist at Kaiser
Permanente Ohio
- Laura Earl, RN at the University
Hospital of New Mexico
- Janet Jensen, RN at Salem
Hospital
- Teresa Hodgkins, Pharmacist and
Director at Desert Medical Group, Palm Springs
- Lisa Vaughn, RN at Wenatchee
Valley Medical Center
- Richard Creamer, Supervisor at
Kaiser Permanente Colorado
We are in need
of further speakers to contribute to the success of the day. If
anyone would be interested in giving a short presentation,
rather like what is mentioned above, then again we would be keen
to hear from you.
|
Study Suggests Lower Risk of
Prostate Cancer in Warfarin Users |
|
 According
to a new study carried out in Canada recently, men who had used
warfarin for four years were 20% less likely to develop prostate
cancer than men not taking warfarin.
Researchers conducted the study using more than 19,000 people
with cancer of the kidney, ovary, uterus, prostate or urinary
bladder, compared with a group of more than 116,000 individuals
without cancer.
It was found that warfarin use did not affect the occurence
of 4 out of 5 types of cancer, but the male individuals using
warfarin were 20% less likely to develop prostate cancer.
A new indication for warfarin?? Further studies are needed to
support these findings.
To view the full article, please follow the link below:
http://patient.cancerconsultants.com/CancerNews.aspx?DocumentId=39899
|
